Numan raises $20M debt funding from Kreos Capital, completing its $60.1M Series B
Summary
It completes a $60.1M Series B round, which was led by White Star Capital, with participation from Novator, VNV Global, and Anthemis Exponential. Offering a digital-first service, Numan provides men with treatments for erectile dysfunction, premature ejaculation, hair loss, and nutritional deficiencies on its proprietary, integrated-care platform. With the additional funding, the company will accelerate its development of new therapeutic areas for men’s health, accelerate industry partnerships and facilitate international expansion, building on the strong momentum that saw Numan grow revenue by a rate of 190% since its Series A. Sokratis Papafloratos, CEO & founder, Numan commented, ‘This most recent funding round is a significant milestone on our journey to help millions of men take better care of themselves. We are delighted to be working with Kreos Capital alongside our wider team of brilliant investors and look forward to this next stage of accelerating Numan’s plans. We’re building a new model around care with the patient at its centre, and this funding enables us to invest even further in our product, technology and growth.” Sean Dunne, partner at Kreos Capital, commented, ‘We are excited by the progress that Sokratis and the wider team at Numan have made to date in building a leading digital platform for men’s health in Europe.